Indica Labs Advances Breast Cancer AI with Zero-Click Tissue Classification Prior to Biomarker Analysis
recent articles
Albuquerque, NM, July 28, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced new intelligent tissue classification capabilities for HALO Breast IHC AI, its AI-powered breast...
From the Lumea blog: We are thrilled to announce that we received a global award for exception achievement from the international awards program The Global Recognition Awards™. We couldn’t be prouder of our team and the countless hours...
Aiforia is helping University Hospital Southampton NHS Foundation Trust support faster, more consistent pathology workflows on Microsoft Azure through AI-assisted lung cancer analysis. For years, the...
Ibex: The clinical validation and regulatory certification of Ibex's breast IHC workflow is expected to further boost pathology lab performance and enhance patient care BOSTON & TEL AVIV, Israel--(BUSINESS WIRE)--Ibex...
Roche: Supporting ADLM's focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and...
OREM, UT, UNITED STATES, July 21, 2026 /EINPresswire.com/ -- Techcyte, a worldwide leader in AI-powered digital pathology and diagnostics, today announced it has surpassed 11 million AI-assisted scans processed across active customer...
































